EASTONBIOPHARMACEUTICALS(SH:688513) Xin Lang Cai Jing·2025-09-12 03:21Group 1 - The core viewpoint of the news is that Yuan Dong Bio has seen a stock price increase of 5.03%, reaching 55.55 CNY per share, with a total market capitalization of 9.806 billion CNY [1] - Yuan Dong Bio, established on June 1, 2009, and listed on September 2, 2020, specializes in the research, production, and sales of chemical raw materials and chemical drug formulations [1] - The company's main revenue sources are: 78.75% from formulation sales, 9.22% from raw material sales, 6.79% from technical services and transfers, 4.01% from CMO/CDMO, and 1.22% from other sources [1] Group 2 - From the perspective of fund holdings, Hongde Fund has a significant position in Yuan Dong Bio, with its Hongde Medical Innovation Mixed Fund A (012481) holding 27,000 shares, accounting for 7.84% of the fund's net value [2] - The fund has generated an estimated floating profit of approximately 71,800 CNY today [2] - The Hongde Medical Innovation Mixed Fund A was established on February 22, 2023, with a current scale of 10.4748 million CNY and has achieved a year-to-date return of 55.59% [2]